The Efficacy and Safety of Empagliflozin - Linagliptin and Empagliflozin- Metformin Therapy in Reduction of Body Weight in Type 2 Diabetic Patients .
Clinical trial NCT07247656 · COMPLETED
Trial details
- NCT number
- NCT07247656
- Sponsor
- Bahria University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2023-03-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.